|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 1692182 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04798998.3 |
| Date of filing the European patent application | 2004-11-05 | |
| (97) | Date of publication of the European application | 2006-08-23 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-07 |
| (46) | Date of publication of the claims translation | 2010-07-26 |
| (86) | Number | PCT/IB2004/003896 |
| Date | 2004-11-05 |
| (87) | Number | WO 2005/044859 |
| Date | 2005-05-19 |
| (30) | Number | Date | Country code |
| 517096 P | 2003-11-05 | US |
| (72) |
UMANA, Pablo, CH
BRÜNKER, Peter, CH
FERRARA KOLLER, Claudia, CH
SUTER, Tobias, CH
PÜNTENER, Ursula, CH
MÖSSNER, Ekkehard, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren-Zuerich,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CD20 antikūnai su padidintu Fc receptoriaus prisirišimo giminingumu ir efektoriaus funkcija |
| CD20 ANTIBODIES WITH INCREASED FC RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION |
| Payment date | Validity (years) | Amount | |
| 2023-10-19 | 347.00 EUR |